LEVI Insider Filing: 82 Class A DERs and 320 Class B DERs Reported

Rhea-AI Filing Summary

Alstead Troy, a director of Levi Strauss & Co. (LEVI), reported acquisitions on Form 4 dated 08/08/2025. The filing shows the acquisition of 82 dividend equivalent rights (DERs) tied to Class A common stock and 320 DERs tied to Class B common stock.

After the transactions the report lists 122,616 shares of Class A common stock beneficially owned and 46,169 derivative securities beneficially owned. The Class A DERs vest 100% on the earlier of the day before the next annual meeting or the first anniversary of grant; the Class B DERs are fully vested and the underlying Class B shares are convertible into Class A shares and subject to a deferred delivery feature. The form is signed by an attorney-in-fact on 08/12/2025.

Positive

• Acquisition recorded: 82 DERs tied to Class A common stock were acquired on 08/08/2025.
• Fully vested grant: 320 DERs tied to Class B common stock are reported as fully vested.
• Post-transaction ownership disclosed: The filing shows 122,616 Class A shares and 46,169 derivative securities beneficially owned following the transactions.

Negative

• None.

Insights

Corporate Governance Expert

TL;DR: Routine director award recorded; shows vested and unvested DERs increasing reported beneficial ownership, with standard vesting and deferral terms.

The Form 4 documents equity awards to a board member rather than open-market purchases or dispositions. It details 82 Class A DERs with a specified vesting event and 320 Class B DERs that are fully vested but subject to deferred delivery. These are standard compensation mechanisms for directors and do not, by themselves, indicate a change in control or material corporate action. The filing is informational and customary for director compensation reporting.

Securities Analyst

TL;DR: Transaction codes show acquisitions at $0.00 price (awards/DERs); no sales or market purchases reported, so immediate market impact is likely limited.

The Form 4 reports acquisitions coded as awards with a price of $0.00, consistent with dividend equivalent rights and deferred equity grants. It also discloses the conversion feature of Class B into Class A shares and the post-transaction beneficial ownership figures of 122,616 Class A and 46,169 derivative securities. From a securities perspective, these entries are routine insider disclosures required under Section 16 and do not reflect cash transactions or exercises that would immediately affect outstanding publicly traded shares.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Alstead Troy

(Last) (First) (Middle)

C/O LEVI STRAUSS & CO.

1155 BATTERY STREET

(Street)

SAN FRANCISCO CA 94111

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
LEVI STRAUSS & CO [ LEVI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/08/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	08/08/2025		A		82(1)	A	$0.00	122,616	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Class B Common Stock	$0.00(2)	08/08/2025		A		320(3)		(2)	(2)	Class A Common Stock	320	$0.00	46,169	D

Explanation of Responses:

1. Represents dividend equivalent rights (DERs), each of which represents a contingent right to receive one share of the issuer's Class A Common Stock upon settlement. The DERs shall vest as to 100% of the shares on the earlier of the day before the next Annual Stockholder Meeting or the first anniversary of the date of grant of the underlying award.

2. Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.

3. Represents DERs, each of which represents a contingent right to receive one share of the issuer's Class B Common Stock upon settlement. The DERs are fully vested. The underlying shares of Class B Common Stock issuable pursuant to the DERs are subject to a deferral delivery feature.

	/s/ Priscilla Duncan-Tannous, Attorney-in-Fact	08/12/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Alstead Troy report on the LEVI Form 4?

The filing reports acquisitions on 08/08/2025 of 82 Class A DERs and 320 Class B DERs, with post-transaction ownership shown as 122,616 Class A and 46,169 derivatives.

What are the vesting terms for the Class A DERs reported by LEVI director Alstead Troy?

The Class A DERs "vest as to 100% of the shares on the earlier of the day before the next Annual Stockholder Meeting or the first anniversary of the date of grant" as stated in the filing.

Are the Class B DERs reported by Alstead Troy vested and convertible?

Yes. The filing states the 320 Class B DERs are fully vested. Each Class B share is convertible into one Class A share at the holder's option and the underlying Class B shares issuable pursuant to the DERs are subject to a deferred delivery feature.

Did Alstead Troy purchase shares on the open market according to the Form 4?

No. The transactions are recorded as awards/DERs with a reported price of $0.00, indicating they are compensation-related grants rather than open-market purchases.

When was the Form 4 signed and filed for the LEVI reporting?

The signature block shows the form was signed by an attorney-in-fact on 08/12/2025.